RueOne Investments

RueOne Investments, founded in 2016, is a New York-based private investment firm that focuses on venture to growth stage companies within FinTech, InsurTech, and Enterprise Software. Their innovative approach allows family offices, institutional, and strategic investors to engage in direct and co-investment opportunities, leveraging RueOne's expertise in sourcing, structuring, and due diligence to maximize investment value. Notable investments in RueOne's portfolio include Ceres Imaging, which delivers AI-powered irrigation management solutions for agriculture, and Adcuratio, a media tech company revolutionizing TV ad targeting. Another significant investment is Elidah, a FemTech firm behind ELITONE, the first FDA-approved non-invasive treatment for stress urinary incontinence. RueOne’s strategy emphasizes long-term value creation, supporting companies that have achieved product-market fit and show multiple levers for value creation. They typically invest between $1 million and $20 million, with the ability to scale larger through co-investments. RueOne prefers companies that can leverage technology for scalable business models with attractive margins. The firm is backed by a network of over 130 investment partners, including operating executives and technical experts, who provide additional value post-investment. This extensive network aids in thorough due diligence and enhances the growth potential of portfolio companies. RueOne is committed to partnering with visionary entrepreneurs and management teams, driving growth, making strategic acquisitions, and increasing asset value for shareholders, all while providing transparency and control to their investors.